Allakos Inc. (ALLK) SEC Filing 8-K Material Event for the period ending Wednesday, May 25, 2022

Allakos Inc.

CIK: 1564824 Ticker: ALLK

View differences made from one to another to evaluate Allakos Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Allakos Inc..


Assess how Allakos Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Allakos Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Ticker: ALLK
CIK: 1564824
Form Type: 8-K Corporate News
Accession Number: 0000950170-22-010854
Submitted to the SEC: Fri May 27 2022 4:05:42 PM EST
Accepted by the SEC: Fri May 27 2022
Period: Wednesday, May 25, 2022
Industry: Pharmaceutical Preparations
  1. Vote of Security Holders

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: